FDA Clearance Tracker · P950002-S011
BAK VISTA INTERBODY FUSION DEVICE
Last checked: Nov 20, 2026Latest source record: Jul 8, 2003 (this decision)Source: openFDAMethods & limitations
Decided
Jul 8, 2003
Approved
Time to decision
313 days
Received Aug 29, 2002. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class II
The decision
- FDA number
- P950002-S011
- Device name
- BAK VISTA INTERBODY FUSION DEVICE
- Applicant
- Zimmer Spine, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Aug 29, 2002
- Decided
- Jul 8, 2003
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P950002
Device type
- Device class
- Class II
- Regulation
- 21 CFR 888.3080
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
APPROVAL TO ADD THE BAK VISTA INTERBODY FUSION DEVICE, WHICH IS MANUFACTURED FROM 65% PEEK OPTIMA AND 35% TOHO BESFIGHT C6-UH CARBON FIBER, TO THE APPROVED PRODUCT LINE FOR THE BAK INTERBODY FUSION SYSTEM. THE DEVICE WILL BE MARKETED UNDER THE TRADE NAME BAK VISTA INTERBODY FUSION DEVICE AND IS INDICATED FOR USE WITH AUTOGENOUS BONE GRAFT IN PATIENTS WITH DEGENERATIVE DISC DISEASE (DDD) AT THE L2-S1 SPINAL LEVELS. THESE DDD PATIENTS MAY ALSO HAVE UP TO GRADE I SPONDYLOLISTHESIS OR RETROLISTHESIS AT THE INVOLVED LEVEL(S). BAK DEVICES ARE TO BE IMPLANTED VIA AN OPEN ANTERIOR OR POSTERIOR APPROACH. DDD IS DEFINED AS DISCOGENIC BACK PAIN WITH DEGENERATION OF THE DISC CONFIRMED BY HISTORY AND RADIOGRAPHIC STUDIES. THESE PATIENTS SHOULD BE SKELETALLY MATURE AND HAVE HAD SIX MONTHS OF NON-OPERATIVE TREATMENT.
Source documents
Other decisions for Zimmer Spine, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K153631 · Decided Feb 16, 2016 · 60 days after receipt
Device type: Posterior Cervical Screw System (NKG) · Orthopedic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.